journal article·2024-05-02Open access

Plasmalogens Alter the Aggregation Rate of Transthyretin and Lower Toxicity of Transthyretin Fibrils

Jadon Sitton, Abid Ali, Luke Osborne, Aidan P. Holman, Axell Rodriguez, Dmitry Kurouski

Abstract

Heart tissue can experience a progressive accumulation of transthyretin (TTR), a small four subunit protein that transports holoretinol binding protein and thyroxine. This severe pathology is known as transthyretin amyloid cardiomyopathy. Numerous experimental studies indicated that the aggregation rate and toxicity of TTR fibrils could be altered by the presence of lipids; however, the role of plasmalogens in this process remains unknown. In this study, we investigate the effect of choline plasmalogens (CPs) with different lengths and saturations of fatty acids (FAs) on TTR aggregation. We found that CPs with saturated and unsaturated FAs strongly suppressed TTR aggregation. We also found that CPs with saturated FAs did not change the morphology of TTR fibrils; however, much thicker fibrillar species were formed in the presence of CPs with unsaturated FAs. Finally, we found that CPs with C16:0, C18:0, and C18:1 FAs substantially lowered the cytotoxicity of TTR fibrils that were formed in their presence.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Amyloidosis: Diagnosis, Treatment, Outcomes · Peroxisome Proliferator-Activated Receptors · Fibroblast Growth Factor Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States

Department of Entomology, Texas A&M University, College Station, Texas 77843, United States

Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843, United States

Funding

National Institute of General Medical Sciences

References (44)

Show source-provided references
1. 10.1016/0022-2836(78)90368-610.1016/0022-2836(78)90368-6 ↗
2. 10.1016/S0021-9258(19)42128-510.1016/S0021-9258(19)42128-5 ↗
3. 10.2174/09298671280026923610.2174/092986712800269236 ↗
4. 10.1038/s41467-019-08609-z10.1038/s41467-019-08609-z ↗
5. 10.1016/j.jacc.2019.04.00310.1016/j.jacc.2019.04.003 ↗
6. 10.1016/j.cpcardiol.2023.10205710.1016/j.cpcardiol.2023.102057 ↗
7. 10.1021/bi500739q10.1021/bi500739q ↗
8. 10.3390/biomedicines1008190610.3390/biomedicines10081906 ↗
9. 10.1371/journal.pone.004499210.1371/journal.pone.0044992 ↗
10. 10.1006/jmbi.2000.441510.1006/jmbi.2000.4415 ↗
11. 10.1001/archneur.62.7.105710.1001/archneur.62.7.1057 ↗
12. 10.1021/bi00151a03610.1021/bi00151a036 ↗
13. 10.1016/S0065-3233(08)60321-610.1016/S0065-3233(08)60321-6 ↗
14. 10.1021/bi952501g10.1021/bi952501g ↗
15. 10.1111/acel.1266510.1111/acel.12665 ↗
16. 10.1073/pnas.040006210110.1073/pnas.0400062101 ↗
17. 10.1038/s41467-022-33591-410.1038/s41467-022-33591-4 ↗
18. 10.1038/s41467-019-13038-z10.1038/s41467-019-13038-z ↗
19. 10.1016/j.ijbiomac.2023.12724110.1016/j.ijbiomac.2023.127241 ↗
20. 10.1016/j.chemphyslip.2023.10535010.1016/j.chemphyslip.2023.105350 ↗
21. 10.1021/acschemneuro.3c0035710.1021/acschemneuro.3c00357 ↗
22. 10.3389/fphys.2021.73082910.3389/fphys.2021.730829 ↗
23. 10.1371/journal.pone.020570610.1371/journal.pone.0205706 ↗
24. 10.1186/s12944-018-0685-910.1186/s12944-018-0685-9 ↗
25. 10.1016/j.ijbiomac.2024.13063210.1016/j.ijbiomac.2024.130632 ↗
26. 10.1002/pro.483810.1002/pro.4838 ↗
27. 10.1038/s41467-020-20782-010.1038/s41467-020-20782-0 ↗
28. 10.1038/ncomms883110.1038/ncomms8831 ↗
29. 10.1038/srep3115510.1038/srep31155 ↗
30. 10.1063/1.342921410.1063/1.3429214 ↗
31. 10.1021/acs.chemrev.6b0044810.1021/acs.chemrev.6b00448 ↗
32. 10.1366/12-0680410.1366/12-06804 ↗
33. 10.1021/acs.analchem.7b0387810.1021/acs.analchem.7b03878 ↗
34. 10.1021/acsnano.8b0142510.1021/acsnano.8b01425 ↗
35. 10.1146/annurev-anchem-071114-04043510.1146/annurev-anchem-071114-040435 ↗
36. 10.1021/acs.nanolett.7b0240410.1021/acs.nanolett.7b02404 ↗
37. 10.1039/D2CS00095D10.1039/D2CS00095D ↗
38. 10.1016/j.bbamem.2017.05.01210.1016/j.bbamem.2017.05.012 ↗
39. 10.1016/j.jbc.2023.10538310.1016/j.jbc.2023.105383 ↗
40. 10.1074/jbc.M116.76409210.1074/jbc.M116.764092 ↗
41. 10.1111/febs.1673810.1111/febs.16738 ↗
42. 10.1016/j.bbamem.2007.09.01810.1016/j.bbamem.2007.09.018 ↗
43. 10.1186/s12944-019-1044-110.1186/s12944-019-1044-1 ↗
44. 10.3389/fmolb.2022.81532010.3389/fmolb.2022.815320 ↗